Pharmafile Logo

News and Press Releases

Cherwell supports microbiological environmental monitoring best practices conference

Cleanroom microbiology experts on hand at Pharmig’s specialist conference to discuss assessment of sterility in pharmaceutical manufacturing facilities 6 March 2025 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert,...

Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: March 6, 2025

Cherwell Laboratories
sales@cherwell-labs.co.uk
Launton Business Centre Murdock Rd, Bicester OX26 4XB

ELRIG Announces Drs Jue Wang and Robert Grundy as Keynote Speakers at Research & Innovation 2025

24 January 2025 -- Cambridge, UK -- The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 24, 2025

European Laboratory Research and Innovation Group (ELRIG)
info@elrig.org
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

From Discovery Park to Merck, Top Industry Players to Showcase at London Biotechnology Show 2025

7 November 2024 -- London, UK -- Back for its second year, the London Biotechnology Show (#LBS25) gathers prominent biotech leaders, policymakers, and industry enthusiasts for an unparalleled showcase. Attendees...

Category: Biotechnology, Other, Pharmaceutical
Posted: November 7, 2024

London Biotechnology Show
info@londonbiotechshow.com

PTC Therapeutics to Participate at Upcoming Investor Conferences

4 November 2024 -- New Jersey, US -- PTC Therapeutics, Inc today announced that the company will present a company overview at the following conferences: UBS Global Healthcare ConferenceWednesday, Nov....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 4, 2024

PTC Therapeutics
info@ptcbio.com
PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449

Travere Therapeutics to Present at Upcoming Investor Conferences

4 November 2024 -- California, US -- Travere Therapeutics, Inc today announced that company management will present in the following upcoming investor conferences in November: Guggenheim Securities Healthcare Innovation ConferenceMonday, November 11,...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 4, 2024

Travere Therapeutics
3611 Valley Centre Drive, Suite 300 San Diego, CA 92130

atai Life Sciences Announces Update on Beckley Psytech’s phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from phase 1 and First Patients Dosed in phase 2a

ELE-101 is a patent-protected, synthetic formulation of psilocin, designed to offer the therapeutic benefits of psilocybin in a more consistent, controllable and shorter treatment paradigm of approximately two hours The...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: June 21, 2024

Beckley Psytech
info@beckleypsytech.com
Beckley Park Beckley OXFORD, OX3 9SY United Kingdom

Numinus Wellness Announces Strategic Acquisition of MedBright AI

Plans name change to "Numinus Intelligence" leveraging its current revenue-generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright's AI-enabled clinical solution capabilities with Numinus'...

Category: Clinical Trials, Other, Pharmaceutical
Posted: June 20, 2024

Numinus

First participant dosed in research study investigating the effects of BPL-003, a novel formulation of 5-MeO-DMT, on the human brain

The study is the first of its kind to assess the effects of 5-MeO-DMT in the human brain and will investigate the neurophysiological effects of BPL-003, Beckley Psytech’s novel synthetic...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 3, 2024

Beckley Psytech
info@beckleypsytech.com
Beckley Park Beckley OXFORD, OX3 9SY United Kingdom

Lykos Therapeutics Appoints Finance Veteran Scott Giacobello to the Board of Directors

30 May 2024 -- California, US -- Lykos Therapeutics, a company dedicated to transforming mental healthcare, announced the appointment of finance veteran Scott Giacobello to the company's Board of Directors, effective immediately. A...

Category: Biotechnology, Clinical Trials, Other
Posted: May 30, 2024

Lykos Therapeutics
media@lykospbc.com 
3141 Stevens Creek Blvd Suite 40547 San Jose, CA 95117

Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied

10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and...

Category: Biotechnology
Posted: May 10, 2024

London Biotechnology Show
info@londonbiotechshow.com